Drug
Hmpl A830
Hmpl A830: highest development phase Phase 1/2, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| HMPL-A830 NCT07718581 | Phase 1/2 | Solid Tumor, Adult |
Latest
No recent events.
Follow Hmpl A830 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.